Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy
Publication
, Journal Article
Farnier, M; Ducobu, J; Bryniarski, L
Published in: Current Medical Research and Opinion
November 2011
Duke Scholars
Published In
Current Medical Research and Opinion
DOI
EISSN
1473-4877
ISSN
0300-7995
Publication Date
November 2011
Volume
27
Issue
11
Start / End Page
2165 / 2173
Publisher
Informa Healthcare
Related Subject Headings
- General & Internal Medicine
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 14 Economics
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Farnier, M., Ducobu, J., & Bryniarski, L. (2011). Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy. Current Medical Research and Opinion, 27(11), 2165–2173. https://doi.org/10.1185/03007995.2011.626398
Farnier, Michel, Jean Ducobu, and Leszek Bryniarski. “Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.” Current Medical Research and Opinion 27, no. 11 (November 2011): 2165–73. https://doi.org/10.1185/03007995.2011.626398.
Farnier M, Ducobu J, Bryniarski L. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy. Current Medical Research and Opinion. 2011 Nov;27(11):2165–73.
Farnier, Michel, et al. “Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.” Current Medical Research and Opinion, vol. 27, no. 11, Informa Healthcare, Nov. 2011, pp. 2165–73. Crossref, doi:10.1185/03007995.2011.626398.
Farnier M, Ducobu J, Bryniarski L. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy. Current Medical Research and Opinion. Informa Healthcare; 2011 Nov;27(11):2165–2173.
Published In
Current Medical Research and Opinion
DOI
EISSN
1473-4877
ISSN
0300-7995
Publication Date
November 2011
Volume
27
Issue
11
Start / End Page
2165 / 2173
Publisher
Informa Healthcare
Related Subject Headings
- General & Internal Medicine
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 14 Economics
- 11 Medical and Health Sciences